The DOI matches its Crossref record; 58 of the 60 references it cites were found in a registry or an index.
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome
Open accessAbstract
Background & aims The mechanisms underlying abdominal pain perception in irritable bowel syndrome (IBS) are poorly understood. Intestinal mast cell infiltration may perturb nerve function leading to symptom perception. We assessed colonic mast cell infiltration, mediator release, and spatial interactions with mucosal innervation and their correlation with abdominal pain in IBS patients.Methods IBS patients were diagnosed according to Rome II criteria and abdominal pain quantified according to a validated questionnaire. Colonic mucosal mast cells were identified immunohistochemically and quantified with a computer-assisted counting method. Mast cell tryptase and histamine release were analyzed immunoenzymatically. Intestinal nerve to mast cell distance was assessed with electron microscopy.Results Thirty-four out of 44 IBS patients (77%) showed an increased area of mucosa occupied by mast cells as compared with controls (9.2% +/- 2.5% vs. 3.3 +/- 0.8%, respectively; P < 0.001). There was a 150% increase in the number of degranulating mast cells (4.76 +/- 3.18/field vs. 2.42 +/- 2.26/field, respectively; P = 0.026). Mucosal content of tryptase was increased in IBS and mast cells spontaneously released more tryptase (3.22 +/- 3.48 pmol/min/mg vs. 0.87 +/- 0.65 pmol/min/mg, respectively; P = 0.015) and histamine (339.7 +/- 59.0 ng/g vs. 169.3 +/- 130.6 ng/g, respectively; P = 0.015). Mast cells located within 5 microm of nerve fibers were 7.14 +/- 3.87/field vs. 2.27 +/- 1.63/field in IBS vs. controls (P < 0.001). Only mast cells in close proximity to nerves were significantly correlated with severity and frequency of abdominal pain/discomfort (P < 0.001 and P = 0.003, respectively).Conclusions Colonic mast cell infiltration and mediator release in proximity to mucosal innervation may contribute to abdominal pain perception in IBS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, approximately 70%–84% of patients with IBS exhibit local mast cell infiltration of mast cells in their intestinal tissues.”
From Nociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, the phenomenon of mast cell infiltration surrounding intestinal nerves occurs approximately three times more frequently in IBS patients than in controls, and the number of degranulated mast cells is increased by approximately 1.5-fold (72).”
From Nociplastic pain: the prominent role of non-neuronal cells in central and peripheral sensitization (2026) · cites this paper as [72]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mucosal mast cell degranulation within the gut can affect host intestinal integrity (Santos et al., 2001) and has been related to visceral pain (Barbara et al., 2004).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Barbara et al., 2004
The cited source says what the claim attributes to it.
In the citing paper
“The severity and frequency of abdominal pain correlates with the presence of activated mast cells in close proximity to nerve endings in the gut mucosa in some studies, 56 but in others mast cell proliferation associates with a reduction, 57 or no change, 58 in visceral sensitivity.”
From British Society of Gastroenterology guidelines on the management of irritable bowel syndrome (2021) · cites this paper as [56]
In the citing paper
“An increase in mucosal immune cells including mast cells, macrophages or monocytes, T-cells, and eosinophils has been reported in both pediatric and adult FGID populations79, 113, 114.”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [113]
In the citing paper
“Mast cells were located in closer vicinity to mucosal innervation and correlated with the severity and frequency of abdominal pain in patients with IBS.152”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [152]
In the citing paper
“Studies on mast cells and cytokines point out that inflammation is present in IBS. 2, 13-20”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [13]
In the citing paper
“Evidence supporting this hypothesis includes increased concentrations of inflammatory/immune cells in intestinal tissue from IBS patients, altered levels of pro- and anti-inflammatory cytokines in the GI tract and peripheral blood of patients with IBS (Table 1) (11, 13, 24, 36, 46, 50, 51, 62, 73, 75, 89, 90, 94, 98, 102, 118, 121–124, 168, 174, 185, 187), and IBS-associated polymorphisms in genes”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“Other studies have reported elevated levels of histamine and tryptase release in patients with IBS compared with controls (11, 13, 35, 73).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“Evidence supporting this hypothesis includes increased concentrations of inflammatory/immune cells in intestinal tissue from IBS patients, altered levels of pro- and anti-inflammatory cytokines in the GI tract and peripheral blood of patients with IBS (Table 1) (11, 13, 24, 36, 46, 50, 51, 62, 73, 75, 89, 90, 94, 98, 102, 118, 121–124, 168, 174, 185, 187), and IBS-associated polymorphisms in genes”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“Notably, some studies demonstrated an increase in activated mast cells in biopsies from specific regions of the GI tract (i.e., cecum and terminal ileum) but not from other regions (e.g., ascending colon, descending colon, rectum) (89, 121, 187), whereas other studies have found activated mast cells in the descending colon (11, 13).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“Several studies have demonstrated increased concentrations of activated mast cells in patients with IBS compared with controls (11, 13, 24, 46, 89, 94, 121, 187).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“Interestingly, the activated mast cells were found to be in close proximity to enteric nerves and correlated with abdominal pain/discomfort (11).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“At the peripheral level, the close interaction between the immune system and the ENS in IBS is demonstrated by the increased infiltration of mast cells in the colonic mucosa in close proximity to enteric nerve fibers and by the increased number of sensory nerve fibers surrounding the mast cells (2, 11, 13).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“One study that supports this association demonstrated a strong correlation between number of infiltrated colonic mast cells around nerves and the severity and frequency of abdominal pain in patients with IBS (11).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
In the citing paper
“In addition, human and animal studies have shown anatomical changes in the enteric nervous system (ENS) around inflammatory infiltrates in the gut wall (2, 11, 13).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [11]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measurement of protein using bicinchoninic acid
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., & Klenk, D. C. (1985) · Analytical Biochemistry · doi:10.1016/0003-2697(85)90442-7 · Cited by 18,482
Functional bowel disorders and functional abdominal pain
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller-Lissner, S. A. (1999) · Gut · doi:10.1136/gut.45.2008.ii43 · Cited by 2,440
Metcalfe, D. D., Baram, D., & Mekori, Y. A. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1033 · Cited by 1,723
Proteinase-activated Receptors
Macfarlane, S. R., Seatter, M. J., Kanke, T., Hunter, G. D., & Plevin, R. J. (2006) · Springer eBooks · doi:10.1007/3-540-29832-0_1335 · Cited by 1,137
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Activation of the mucosal immune system in irritable bowel syndrome
Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833
The role of psychological and biological factors in postinfective gut dysfunction
Gwee, K.-A., Leong, Y.-L., Graham, C., McKendrick, M. W., Collins, S. M., Walters, S. J., Underwood, J. E., & Read, N. W. (1999) · Gut · doi:10.1136/gut.44.3.400 · Cited by 764
Self-citationInteractions of Mast Cell Tryptase with Thrombin Receptors and PAR-2
Molino, M., Barnathan, E. S., Numerof, R. P., Clark, J., Dreyer, M. L., Cumashi, A., Hoxie, J. A., Schechter, N. M., Woolkalís, M. J., & Brass, L. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4043 · Cited by 592
Effects of gender and sex steroids on the immune response
Schuurs, A. H. W. M., & Verheul, H. A. M. (1990) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(90)90270-3 · Cited by 587
Neal, K. R., Hebden, J., & Spiller, R. (1997) · BMJ · doi:10.1136/bmj.314.7083.779 · Cited by 586
Flagged first, then by citations
2 of the 60 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 1,001
Gebhardt, T., Lorentz, A., Detmer, F., Trautwein, C., Bektas, H., Manns, M. P., & Bischoff, S. C. (2005) · Gut · doi:10.1136/gut.2004.054650 · Cited by 78
Probiotics as a Treatment Strategy for Gastrointestinal Diseases?
Bergonzelli, G. E., Blum, S., Brüssow, H., & Corthesy-Theulaz, I. E. (2005) · Digestion · doi:10.1159/000087638 · Cited by 78
Sanger, G. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705742 · Cited by 78
Carroccio, A., Brusca, I., Mansueto, P., Soresi, M., D'Alcamo, A., Ambrosiano, G., Pepe, I., Iacono, G., Lospalluti, M. L., La Chiusa, S. M., et al. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.07.030 · Cited by 75
Probiotics in the Management of Functional Bowel Disorders
Quigley, E. M. M. (2012) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2012.08.005 · Cited by 77
Implications of SARS‐CoV‐2 infection for neurogastroenterology
Marasco, G., Lenti, M. V., Cremon, C., Barbaro, M. R., Stanghellini, V., Sabatino, A. D., & Barbara, G. (2021) · Neurogastroenterology & Motility · doi:10.1111/nmo.14104 · Cited by 78
Self-citationLayer, P., Andresen, V., Allescher, H. ‐., Bischoff, S. C., Claßen, M., Elsenbruch, S., Freitag, M., Frieling, T., Gebhard, M., Goebel‐Stengel, M., et al. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1591-4794 · Cited by 81
The gut microbiome in disorders of gut–brain interaction
Kraïmi, N., Ross, T., Pujo, J., & Palma, G. D. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2360233 · Cited by 93
Functions and Imaging of Mast Cell and Neural Axis of the Gut
Schemann, M., & Camilleri, M. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.040 · Cited by 77
Mast cell degranulation mediates compound 48/80-induced hyperalgesia in mice
Chatterjea, D., Wetzel, A., Mack, M. R., Engblom, C., Allen, J., Mora-Solano, C., Paredes, L., Balsells, E., & Martinov, T. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.074 · Cited by 77
Halliez, M. C. M., Motta, J., Feener, T. D., Guérin, G., Goff, L. L., François, A., Colasse, É., Favennec, L., Gargala, G., Lapointe, T. K., et al. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00144.2015 · Cited by 83
Jones, M., Chey, W. D., Singh, S., Gong, H., Shringarpure, R., Hoe, N., Chuang, E., & Talley, N. J. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12608 · Cited by 76
ProbioticLactobacillus rhamnosusdownregulatesFCER1andHRH4expression in human mast cells
Oksaharju, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i6.750 · Cited by 76
Duodenal Implications in the Pathophysiology of Functional Dyspepsia
Lee, K. J., & Tack, J. F. (2010) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm.2010.16.3.251 · Cited by 76
Andresen, V., & Camilleri, M. (2006) · Drugs · doi:10.2165/00003495-200666080-00004 · Cited by 77
Feng, B., La, J., Schwartz, E. S., Tanaka, T., McMurray, T. P., & Gebhart, G. F. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2011 · Cited by 75
Drugs Acting on Serotonin Receptors for the Treatment of Functional GI Disorders
Tonini, M., & Pace, F. (2006) · Digestive Diseases · doi:10.1159/000090309 · Cited by 75
Öhman, L., Stridsberg, M., Isaksson, S., Jerlstad, P., & Simrén, M. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.458 · Cited by 74
Cross-organ sensitization between the colon and bladder: to pee or not to pee?
Grundy, L., & Brierley, S. M. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00272.2017 · Cited by 77
BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit
Wang, P., Du, C., Chen, F.-X., Li, C., Yu, Y.-B., Han, T., Akhtar, S., Zuo, X.-L., Tan, X., & Li, Y. (2016) · Scientific Reports · doi:10.1038/srep20320 · Cited by 72
Lactobacillus reuteri DSM 17938 in the Treatment of Functional Abdominal Pain in Children: RCT Study
Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001478 · Cited by 71
Gut microbiota: a new avenue to reveal pathological mechanisms of constipation
Yang, L., Wang, Y., Zhang, Y. L., Li, W., Jiang, S., Qian, D., & Duan, J. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-022-12197-2 · Cited by 75
Hillsley, K., Lin, J., Stanisz, A., Grundy, D., Aerssens, J., Peeters, P. J., Moechars, D., Coulie, B. J., & Stead, R. H. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.113597 · Cited by 72
Effect of Red Pepper on Symptoms of Irritable Bowel Syndrome: Preliminary Study
Bortolotti, M., & Porta, S. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1740-9 · Cited by 73
Prebiotics and Synbiotics in Clinical Medicine
Bengmark, S., & Martindale, R. G. (2005) · Nutrition in Clinical Practice · doi:10.1177/0115426505020002244 · Cited by 72
Wiet, M., Piscioneri, A., Khan, S. N., Ballinger, M. N., Hoyland, J. A., & Purmessur, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-12666-z · Cited by 74
Current insights into the innate immune system dysfunction in irritable bowel syndrome
Lazaridis, N. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0229 · Cited by 77
Human mast cell mediator cocktail excites neurons in human and guinea‐pig enteric nervous system
Schemann, M., Michel, K., CEREGRZYN, M., Zeller, F., Seidl, S., & Bischoff, S. C. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00591.x · Cited by 72
Quigley, E. M. M. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.009 · Cited by 67
Significance of Conversation between Mast Cells and Nerves
van der Kleij, H. P. M., & Bienenstock, J. (2005) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-1-2-65 · Cited by 71
Irritable bowel syndrome - An inflammatory disease involving mast cells
Philpott, H., Gibson, P. G., & Thien, F. C. K. (2011) · Asia Pacific Allergy · doi:10.5415/apallergy.2011.1.1.36 · Cited by 71
The study on the role of inflammatory cells and mediators in post-infectious functional dyspepsia
Li, X., Chen, H., Lü, H., Li, W., Chen, X., Yansheng, P., & Ge, Z. (2010) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521003632576 · Cited by 71
Inflammatory bowel disease and irritable bowel syndrome
Barbara, G., Cremon, C., & Stanghellini, V. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000070 · Cited by 72
Self-citationHistamine H4 and H1 receptors contribute to postinflammatory visceral hypersensitivity
Deiteren, A., Man, J. G. D., Ruyssers, N. E., Moreels, T. G., Pelckmans, P. A., & Winter, B. Y. D. (2014) · Gut · doi:10.1136/gutjnl-2013-305870 · Cited by 71
Xu, X., Zhang, Y. L., Liu, L., Pan, L., & Yao, S. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13848 · Cited by 72
Balestra, B., Vicini, R., Cremon, C., Zecchi, L., Dothel, G., Vasina, V. I., GIORGIO, R. D., Paccapelo, A., Pastoris, O., Stanghellini, V., et al. (2012) · Neurogastroenterology & Motility · doi:10.1111/nmo.12000 · Cited by 72
Self-citationIncreased responsiveness of rat colonic splanchnic afferents to 5‐HT after inflammation and recovery
Coldwell, J. R., Phillis, B. D., Sutherland, K., Howarth, G. S., & Blackshaw, L. A. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.123158 · Cited by 70
Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV
Stanghellini, V. (2017) · Digestive Diseases · doi:10.1159/000485408 · Cited by 70
Self-citationAbbasnezhad, A., Amani, R., Hajiani, E., Alavinejad, P., Cheraghian, B., & Ghadiri, A. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12851 · Cited by 69
Ultratrace Detection of Histamine Using a Molecularly-Imprinted Polymer-Based Voltammetric Sensor
Akhoundian, M., Rüter, A., & Shinde, S. (2017) · Sensors · doi:10.3390/s17030645 · Cited by 69
van Hoboken, E. A., Thijssen, A. Y., Verhaaren, R., van der Veek, P. P. J., Prins, F. A., Verspaget, H. W., & Masclee, A. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2011.579156 · Cited by 68
Sohn, W., Lee, O. Y., Lee, S. P., Lee, K. N., Jun, D. W., Lee, H. L., Yoon, B. C., Choi, H. S., Sim, J., & Jang, K.-S. (2013) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2013.857712 · Cited by 68
Silos‐Santiago, I., Hannig, G., Eutamène, H., Ustinova, E. E., Bernier, S. G., Ge, P., Graul, C., Jacobson, S., Jin, H. L., Liong, E., et al. (2013) · Pain · doi:10.1016/j.pain.2013.05.044 · Cited by 68
Kikuchi, A., Ohashi, K., Sugie, Y., Sugimoto, H., & Omura, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071599 · Cited by 68
Spiller, R. E. (2004) · British Medical Bulletin · doi:10.1093/bmb/ldh039 · Cited by 68
Subjects with Diarrhea-Predominant IBS Have Increased Rectal Permeability Responsive to Tryptase
Lee, J. W., Park, J., Park, D., Park, J., Kim, H., Cho, Y., Sohn, C., Jeon, W., & Kim, B. I. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1094-8 · Cited by 63
Rahman, M. M., Mahadeva, S., & Ghoshal, U. C. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6788 · Cited by 72
Quigley, E. M. M. (2007) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2007.07.012 · Cited by 67
Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management
Quigley, E. M. M. (2007) · Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2007.00277.x · Cited by 67
Intestinal Permeability in Irritable Bowel Syndrome Patients: Effects of NSAIDs
Kerckhoffs, A., Akkermans, L., de Smet, M. D., Besselink, M. G., Hietbrink, F., Bartelink, I., Busschers, W., Samsom, M., & Renooij, W. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0765-9 · Cited by 69
Mast Cell Involvement in the Pathophysiology of Migraine Headache: A Hypothesis
Levy, D., Burstein, R., & Strassman, A. M. (2006) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2006.00485.x · Cited by 67
Wood, J. D. (2006) · Gut · doi:10.1136/gut.2005.079046 · Cited by 67
Robles, A., Perez Ingles, D., Myneedu, K., Deoker, A., Sarosiek, I., Zuckerman, M. J., Schmulson, M. J., & Bashashati, M. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13718 · Cited by 65
Post COVID-19 irritable bowel syndrome
Marasco, G., Cremon, C., Barbaro, M. R., Cacciari, G., Falangone, F., Валерьевна, К. А., Bordin, D. S., Drug, V. L., Miftode, E. G., Fusaroli, P., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-328483 · Cited by 70
Self-citationMast Cell–Nerve Interactions in Children With Functional Dyspepsia
Schäppi, M. G., Borrelli, O., Knafelz, D., Williams, S., Smith, V. V., Milla, P. J., & Lindley, K. J. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318186008e · Cited by 66
Markers for visceral hypersensitivity in patients with irritable bowel syndrome
Ludidi, S., Mujagic, Z., Jonkers, D. M. A. E., Keszthelyi, D., Hesselink, M., Kruimel, J. W., Conchillo, J. M., & Masclee, A. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12365 · Cited by 66
Vázquez‐Roque, M. I., Camilleri, M., Smyrk, T. C., Murray, J. A., O’Neill, J., Carlson, P., Lamsam, J. L., Eckert, D. J., Janzow, D., Burton, D. B., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00294.2012 · Cited by 67
Pierce, A. N., Silvestro, E. R. D., Eller, O. C., Wang, R., Ryals, J. M., & Christianson, J. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.02.039 · Cited by 68
Mast cells in chronic inflammation, pelvic pain and depression in women
Graziottin, A., Skaper, S. D., & Fusco, M. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.911280 · Cited by 63
Demir, I. E., Schäfer, K.-H., Tieftrunk, E., Friess, H., & Ceyhan, G. O. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1099-4 · Cited by 77
The Influence of Early Life Experience on Visceral Pain
Fuentes, I. M., & Christianson, J. A. (2018) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2018.00002 · Cited by 67
High FODMAP diet causes barrier loss via lipopolysaccharide-mediated mast cell activation
Singh, P., Grabauskas, G., Zhou, S.-Y., Gao, J., Zhang, Y., & Owyang, C. (2021) · JCI Insight · doi:10.1172/jci.insight.146529 · Cited by 66
Nardo, G. D., Barbara, G., Cucchiara, S., Cremon, C., Shulman, R. J., Isoldi, S., Zecchi, L., Drago, L., Oliva, S., Saulle, R., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12250 · Cited by 65
Self-citationSpaziani, R., Bayati, A. I., Redmond, K., Bajaj, H. S., Bienenstock, J., Collins, S. M., & Kamath, M. V. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01042.x · Cited by 64
Self-citationSerotonergic and non‐serotonergic targets in the pharmacotherapy of visceral hypersensitivity
Bueno, L., De Ponti, F., Fried, M., Kullak‐ublick, G. A., Kwiatek, M. A., Pohl, D., Quigley, E. M. M., Tack, J., & Talley, N. J. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00876.x · Cited by 64
Kayssi, A., Amadesi, S., Bautista, F., Bunnett, N. W., & Vanner, S. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2006.126599 · Cited by 64
Self-citationIs irritable bowel syndrome an inflammatory disorder?
De Giorgio, R., & Barbara, G. (2008) · Current Gastroenterology Reports · doi:10.1007/s11894-008-0073-0 · Cited by 64
Self-citationSystematic review: instruments to assess abdominal pain in irritable bowel syndrome
Mujagic, Z., Keszthelyi, D., Aziz, Q., Reinisch, W., Quetglas, E. G., Leonardis, F. D., Segerdahl, M., & Masclee, A. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13378 · Cited by 65
Long, X., Li, M.-X., Li, L. ‐., Sun, Y., Zhang, W. ‐., Zhao, D. ‐., & Li, Y. (2017) · Neurogastroenterology & Motility · doi:10.1111/nmo.13227 · Cited by 64
Mast cells at the crossroads of microbiota and IBD
Zuani, M. D., Secco, C. D., & Frossi, B. (2018) · European Journal of Immunology · doi:10.1002/eji.201847504 · Cited by 62
Borrelli, O., Barbara, G., Nardo, G. D., Cremon, C., Lucarelli, S., Frediani, T., Paganelli, M., GIORGIO, R. D., Stanghellini, V., & Cucchiara, S. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2008.109 · Cited by 63
Self-citationLettesjö, H., Hansson, T., Peterson, C. G. B., Ung, K., Ringström, G., Abrahamsson, H., & Simrén, M. (2005) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520510023909 · Cited by 63
Clarke, G. A., Fitzgerald, P., Hennessy, A. A., Cassidy, E., Quigley, E. M. M., Ross, R. P., Stanton, C., Cryan, J. F., & Dinan, T. G. (2009) · Journal of Lipid Research · doi:10.1194/jlr.p000695 · Cited by 63
González-Castro, A. M., Martínez, C., Salvo‐Romero, E., Fortea, M., Pardo‐Camacho, C., Pérez, T., Alonso, C., Santos, J., & Vicario, M. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13417 · Cited by 66
Ceuleers, H., Spaendonk, H. V., Hanning, N., Heirbaut, J., Lambeir, A., Joossens, J., Augustyns, K., Man, J. G. D., Meester, I. D., & Winter, B. Y. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i47.10275 · Cited by 63
Post-Infectious Irritable Bowel Syndrome
Lee, Y. Y., Chandramouli, A., & Rao, S. S. C. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0595-4 · Cited by 67
Balemans, D., Aguilera‐Lizarraga, J., Florens, M. V., Jain, P., Denadai‐Souza, A., Viola, M. F., Alpizar, Y. A., der Merwe, V., Berghe, P. V., Talavera, K., et al. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00116.2018 · Cited by 63
Ierardi, E. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0165 · Cited by 62
Circadian Rhythms and Melatonin Metabolism in Patients With Disorders of Gut-Brain Interactions
Fowler, S., Hoedt, E. C., Talley, N. J., Keely, S., & Burns, G. L. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.825246 · Cited by 62
Post‐inflammatory modification of colonic afferent mechanosensitivity
Hughes, P. A., Brierley, S. M., & Blackshaw, L. A. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05248.x · Cited by 62
Lobo, B., Ramos, L., Martínez, C., Guilarte, M., González-Castro, A. M., Alonso, C., Pigrau, M., de Torres, I. M., Rodiño‐Janeiro, B. K., Salvo‐Romero, E., et al. (2017) · United European Gastroenterology Journal · doi:10.1177/2050640617691690 · Cited by 62
Mast Cell Activation Syndrome: A Primer for the Gastroenterologist
Weinstock, L. B., Pace, L. A., Rezaie, A., Afrin, L. B., & Molderings, G. J. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06264-9 · Cited by 59
The role of mast cells in the pathogenesis of pain in chronic pancreatitis
Hoogerwerf, W. A., Gondesen, K., Xiao, S.-Y., Winston, J. H., Willis, W. D., & Pasricha, P. J. (2005) · BMC Gastroenterology · doi:10.1186/1471-230x-5-8 · Cited by 61
Probiotics in functional gastrointestinal disorders: what are the facts?
Quigley, E. M. M. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2008.08.007 · Cited by 63
Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity
Mansueto, P., D’Alcamo, A., Seidita, A., & Carroccio, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i23.7089 · Cited by 63
D’Costa, S., Ayyadurai, S., Gibson, A. J., Mackey, E., Rajput, M., Sommerville, L. J., Wilson, N., Li, Y., Kubat, E., Kumar, A. N., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.08.053 · Cited by 58
Ait‐belgnaoui, A., Eutamene, H., Houdeau, E., Bueno, L., Fioramonti, J., & Theodorou, V. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2009.01280.x · Cited by 61
The microbiome and disorders of the central nervous system
Felice, V. D., & O'Mahony, S. M. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.016 · Cited by 60
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
Filippis, D. D., D’Amico, A., & Iuvone, T. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01674.x · Cited by 60
Wei, L., Singh, R., & Ghoshal, U. C. (2022) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm22008 · Cited by 71
Gaining Insight into Microbial Physiology in the Large Intestine: A Special Role for Stable Isotopes
de Graaf, A. A., & Venema, K. (2007) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/s0065-2911(07)53002-x · Cited by 60
Differences between risk factors among irritable bowel syndrome subtypes in Japanese adults
Kubo, M., Fujiwara, Y., Shiba, M., Kohata, Y., Yamagami, H., Tanigawa, T., Watanabe, K., Watanabe, T., Tominaga, K., & Arakawa, T. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01640.x · Cited by 60
Functional abdominal pain and irritable bowel syndrome in children and adolescents
Chiou, E., & Nurko, S. (2011) · Therapy · doi:10.2217/thy.11.7 · Cited by 57
Ahn, J. Y., Lee, K. H., Choi, C. H., Kim, J. W., Lee, H. W., Kim, J. W., Kim, M. K., Kwon, G. Y., Han, S., Kim, S., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2930-4 · Cited by 59
Postinflammatory visceral sensitivity and pain mechanisms
Vergnolle, N. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01110.x · Cited by 60
Changing face of irritable bowel syndrome
Quigley, E. M. M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i1.1 · Cited by 60
Peeters, M., Troost, F. J., Mingels, R., Welsch, T., van Grinsven, B., Vranken, T., Ingebrandt, S., Thoelen, R., Cleij, T. J., & Wagner, P. (2012) · Analytical Chemistry · doi:10.1021/ac3026288 · Cited by 61
Evidence for long-term sensitization of the bowel in patients with post-infectious-IBS
Balemans, D., Mondelaers, S. U., Cibert-Goton, V., Stakenborg, N., Aguilera-Lizarraga, J., Dooley, J., Liston, A., Bulmer, D. C., Vanden Berghe, P., Boeckxstaens, G. E., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-12618-7 · Cited by 60
Novel therapeutic targets for enteric nervous system disorders
GIORGIO, R. D., BARBARA, G., Furness, J. B., & Tonini, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.08.003 · Cited by 60
Self-citationRole of motility in chronic diarrhoea
Spiller, R. E. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00836.x · Cited by 61
Metadata
- Authors
- Barbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., Collins, S. M., & Corinaldesi, R.
- Affiliations
- University of Bologna (IT)
- University of California, San Francisco (US)
- McMaster University (CA)
- Corresponding author
- Barbara, Giovanni
- ORCID
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2004-03
- Volume
- 126
- Issue
- 3
- Pages
- 693-702
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1976068711
- Cited by
- 1,475
- References
- 60
- Citations by year
- 2026: 49 · 2025: 39 · 2024: 49 · 2023: 70 · 2022: 64 · 2021: 74 · 2020: 55 · 2019: 44 · 2018: 74 · 2017: 73 · 2016: 77 · 2015: 71 · 2014: 79 · 2013: 66 · 2012: 84
- FWCI
- 56.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 57840, DK 43207, R01DK057840)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Surgery › Congenital gastrointestinal and neural anomalies
- Keywords
- irritable bowel syndrome, mast cells, abdominal pain, colonic mucosa, enteric nerves, mast cell degranulation, tryptase, histamine release, visceral pain perception, mast cell infiltration
- MeSH terms
- Adult, Aged, Cell Count, Colon, Female, Histamine Release, Humans, Immunohistochemistry, Intestinal Mucosa, Male, Mast Cells, Microscopy, Electron, Middle Aged, Nervous System, Serine Endopeptidases, Blotting, Western, Cell Degranulation, Abdominal Pain, Irritable Bowel Syndrome, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
